Mechanism of glucocorticoid protection of airway smooth muscle from proasthmatic effects of long-acting beta2-adrenoceptor agonist exposure.
about
Scientific rationale for the use of alpha-adrenergic agonists and glucocorticoids in the therapy of pediatric stridor.Beta-agonist-associated reduction in RGS5 expression promotes airway smooth muscle hyper-responsiveness.Directional secretory response of double stranded RNA-induced thymic stromal lymphopoetin (TSLP) and CCL11/eotaxin-1 in human asthmatic airways.A new pathway of glucocorticoid action for asthma treatment through the regulation of PTEN expression.Constitutively active signaling by the G protein βγ-subunit mediates intrinsically increased phosphodiesterase-4 activity in human asthmatic airway smooth muscle cells.Salmeterol Efficacy and Bias in the Activation and Kinase-Mediated Desensitization of β2-Adrenergic Receptors.G Protein βγ-subunit signaling mediates airway hyperresponsiveness and inflammation in allergic asthma.The pharmacogenetics and pharmacogenomics of asthma therapyIL-13-induced changes in endogenous glucocorticoid metabolism in the lung regulate the proasthmatic response.Construction of a cell model of β2-adrenoceptor downregulation.β2-adrenoreceptor Inverse Agonist Down-regulates Muscarine Cholinergic Subtype-3 Receptor and Its Downstream Signal Pathways in Airway Smooth Muscle Cells in vitro.Current concepts on the use of glucocorticosteroids and beta-2-adrenoreceptor agonists to treat childhood asthmaAsthma Pharmacogenomics: 2015 Update.Understanding how long-acting β2 -adrenoceptor agonists enhance the clinical efficacy of inhaled corticosteroids in asthma - an update.RGS5 gene and therapeutic response to short acting bronchodilators in paediatric asthma patients.Phosphodiesterase-4 inhibition improves corticosteroid insensitivity in pulmonary endothelial cells under oxidative stress.Differentiation of human bronchial epithelial cells: role of hydrocortisone in development of ion transport pathways involved in mucociliary clearance.β(2) -adrenoreceptor polymorphisms in asthmatic and non-asthmatic schoolchildren from Colombia and their relationship to treatment response.
P2860
Q30471614-6822A442-ED7C-4929-A3DC-B2D01C31406DQ34719688-6D552967-6031-42A5-B318-231293AE63C2Q34784852-0B004006-1EA0-4653-9845-D104522AD5DEQ34987539-9CEA0AD9-71D2-4632-B275-E4ED5A2E9224Q35572333-6B057328-CA90-42C7-98B3-A1901013DBC5Q35600398-D85FF7F7-4819-4D83-BA4A-96E2C068400CQ35772192-1BA96A33-39F8-481C-8BFD-A6F6CA393C91Q35819993-B8ABF946-2E2B-484D-83F8-8B923A4B521EQ36309185-24FCF000-2B62-414D-8A8D-F5B454878E58Q37128059-D38D4ADD-20D4-4850-8182-383621C43A5DQ37554447-6AD343B8-2E06-48F2-9B0B-12C1C356E7B7Q37694255-5FA78D98-69B9-4352-80D4-CEA00F63635CQ38542847-0FF9C460-2DFD-4C87-BA65-20F2C4021623Q38959067-F3DAC884-5C4D-4600-9735-438F64B45203Q39237406-CB344135-0BB3-4C1A-8664-5A055A8D8B57Q39526549-3269BE65-35CE-441A-9F78-D26292B3765BQ41965367-33A83C48-04D4-481E-9D25-2BE08CE97BB6Q54324492-053762F7-5048-4CC0-BD45-A9F8EFA7DAC3
P2860
Mechanism of glucocorticoid protection of airway smooth muscle from proasthmatic effects of long-acting beta2-adrenoceptor agonist exposure.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Mechanism of glucocorticoid pr ...... adrenoceptor agonist exposure.
@en
type
label
Mechanism of glucocorticoid pr ...... adrenoceptor agonist exposure.
@en
prefLabel
Mechanism of glucocorticoid pr ...... adrenoceptor agonist exposure.
@en
P2093
P2860
P1476
Mechanism of glucocorticoid pr ...... adrenoceptor agonist exposure.
@en
P2093
Gustavo Nino
Judith S Grunstein
Michael M Grunstein
P2860
P304
P356
10.1016/J.JACI.2010.02.007
P407
P577
2010-04-14T00:00:00Z